valproic acid has been researched along with Encapsulating Peritoneal Sclerosis in 1 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Costalonga, EC | 1 |
| de Freitas, LJ | 1 |
| Aragone, DDSP | 1 |
| Silva, FMO | 1 |
| Noronha, IL | 1 |
1 other study available for valproic acid and Encapsulating Peritoneal Sclerosis
| Article | Year |
|---|---|
Anti-fibrotic effects of valproic acid in experimental peritoneal fibrosis.
Topics: Animals; Biological Transport; Biomarkers; Body Weight; Bone Morphogenetic Protein 7; Calcium-Bindin | 2017 |